31-45 of 49
Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes
CME/CE Broadcast ReplayPulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes
Updates From the 7th World Symposium Task Force
CME/CEUpdates From the 7th World Symposium Task Force
Updates on Pulmonary Hypertension Clinical Trials
MinuteCE®Updates on Pulmonary Hypertension Clinical Trials
- advertisement
Macitentan Update: Impact on Management of Pulmonary Hypertension
MinuteCE®Macitentan Update: Impact on Management of Pulmonary Hypertension
Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension
MinuteCE®Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension
Advances in Minimally Invasive Screening for Lung Cancer
CME/CEAdvances in Minimally Invasive Screening for Lung Cancer
Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
CME/CEExpert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
- advertisement
TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
CME/CETROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
Clinical Reflections®: Reflecting on Missed Opportunities in Nontuberculous Mycobacteria Lung Disease
CME/CEClinical Reflections®: Reflecting on Missed Opportunities in Nontuberculous Mycobacteria Lung Disease
Clinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease
CME/CEClinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease



















































































